Skip to main content

Maternal Mortality and Morbidity in Autoimmune Diseases

  • Chapter
  • First Online:
Women's Health in Autoimmune Diseases
  • 412 Accesses

Abstract

Women with autoimmune disorders can present with a myriad of symptoms during pregnancy that sometimes causes catastrophic illness. With greater understanding of the interaction between pregnancy and autoimmune disorders as well as interdisciplinary cooperation among physicians, the maternal and infant prognosis can be greatly improved. Pregnancy should be planned after control of active disease and discussion of risks associated with pregnancy. Systemic lupus erythematosus is the most important disorder and can cause severe complications such as nephropathy, encephalopathy, pulmonary hypertension, multiple organ dysfunction and maternal and infant mortality. Women with autoimmune diseases are also at risk of puerperal sepsis. Other important issues include hypertension, preeclampsia, pulmonary hypertension, cardiac dysfunction and hypercoagulable states. Management should be carried out by a multidisciplinary team comprising of obstetricians, rheumatologists, nephrologists, cardiologists, pulmonary physicians and neonatologists. A one-stop clinic for this special pregnant population should be established for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  1. Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344–2358

    Article  Google Scholar 

  2. Benagiano G, Benagiano M, Bianchi P et al (2019) Contraception in autoimmune diseases. Best Pract Res Clin Obstet Gynaecol 60:111–123

    Google Scholar 

  3. Benagiano M, Bianchi P, D'Elios MM et al (2019) Autoimmune diseases: role of steroid hormones. Best Pract Res Clin Obstet Gynaecol 60:24–34

    Google Scholar 

  4. De Carolis S, Moresi S, Rizzo F et al (2019) Autoimmunity in obstetrics and autoimmune diseases in pregnancy. Best Pract Res Clin Obstet Gynaecol 60:66–76

    Google Scholar 

  5. Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R et al (2019) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases. Autoimmun Rev 18:406–414

    Article  Google Scholar 

  6. Belizna C, Pregnolato F, Abad S et al (2018) HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. Autoimmun Rev 17:1153–1168

    Article  CAS  Google Scholar 

  7. Mekinian A, Alijotas-Reig J, Carrat F et al (2017) Refractory obstetrical antiphospholipid syndrome: features, treatment and outcome in a European multicenter retrospective study. Autoimmun Rev 16:730–734

    Article  Google Scholar 

  8. Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76:476–485

    Article  CAS  Google Scholar 

  9. Andreoli L, Crisafulli F, Tincani A (2017) Pregnancy and reproductive aspects of systemic lupus erythematosus. Curr Opin Rheumatol 29:473–479

    Article  Google Scholar 

  10. Limper M, Scirè CA, Talarico R et al (2018) Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open 4:e000785

    Article  Google Scholar 

  11. Spinillo A, Beneventi F, Locatelli E et al (2016) The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study. BMC Pregnancy Childbirth 16:313

    Article  Google Scholar 

  12. Kamper-Jørgensen M, Gammill HS, Nelson JL (2018) Preeclampsia and scleroderma: a prospective nationwide analysis. Acta Obstet Gynecol Scand 97:587–590

    Article  Google Scholar 

  13. Lidar M, Langevitz P (2012) Pregnancy issues in scleroderma. Autoimmun Rev 11:A515–A519

    Article  Google Scholar 

  14. Sobanski V, Launay D, Depret S et al (2016) Special considerations in pregnant systemic sclerosis patients. Expert Rev Clin Immunol 12:1161–1173

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sikka, P., Brar, R. (2020). Maternal Mortality and Morbidity in Autoimmune Diseases. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-0114-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0114-2_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0113-5

  • Online ISBN: 978-981-15-0114-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics